Cardiovascular therapies and neuromodulation devices by CVRx
Endeavor Health completes initial Barostim device implant with CVRx partnership
CVRx has announced its support for Endeavor Health Northwest Community Hospital in expanding access to the Barostim device for patients with heart failure. The company specifically referenced the ...
CVRx releases case study on ambulatory hemodynamic changes in HFrEF patients
CVRx has announced the publication of a new case study aimed at healthcare providers, focusing on ambulatory hemodynamic changes and strategies for diuretic de-escalation in patients with heart ...
Baylor Scott and White Medical Center conducts initial Barostim implant with CVRx collaboration
CVRx announced a partnership with Drs. Ernesto Ruiz, Lazaros Nikolaidis, Afshin Ehsan, and David Daniel and the team at Baylor Scott and White Medical Center in Temple, Texas, for their first ...
CVRx sets agenda for HFSA2026 to advance Barostim program growth
CVRx is inviting attendees to HFSA2026 for an in-depth discussion on building and sustaining a successful Barostim program. The event will feature a comprehensive look at patient identification, ...
Florida Medical Clinic Orlando Health debuts Barostim device in collaboration with CVRx
CVRx has announced a partnership with Dr. Gilbert Postler, Dr. Michol Cooper, and the team at Florida Medical Clinic Orlando Health for their first Barostim implant. This collaboration allows ...
CVRx enables first Barostim implant at Orlando Health Dr Phillips Hospital
CVRx supported physicians at Orlando Health Dr. Phillips Hospital in performing their first Barostim implant procedure. The hospital's team, including Dr. Mauricio Perez Martinez, Dr. Sotero ...
CVRx advances innovative therapy with 10th Barostim implant at The Heart Hospital Baylor Plano
CVRx announced that The Heart Hospital Baylor Plano team has successfully completed their 10th Barostim implant procedure. Led by Dr. Aasim Afzal, Dr. Dennis Gable, Blen Daniel, NP, and Claire ...
CVRx secures Medicare Advantage coverage for Barostim therapy from Devoted Health
CVRx announced that Devoted Health will offer Medicare Advantage coverage for its Barostim therapy, effective July 17, 2026. Devoted Health is a national health insurance company with the eighth ...
M Health Fairview receives first Barostim implant through CVRx collaboration
CVRx announced a collaboration with M Health Fairview and physicians Dr. Alexandra Mercel and Dr. Yauhen Tarbunou to deliver their first Barostim implant. This milestone brings novel device ...
CVRx unveils Barostim therapy process as Chief Medical Officer details device procedure
CVRx introduces an overview of Barostim therapy through its Chief Medical Officer, Dr. Philip Adamson, MD, MSc, FACC, FESC, FRCP (Ed). Dr. Adamson explains the key steps involved in the Barostim ...
CVRx supports symposium with focus on heart failure treatment advances
CVRx is actively participating in the Kansas City Heart Rhythm Society Symposium this weekend, emphasizing its commitment to advancing care for heart failure patients. The company is highlighting ...
CVRx advances with 6th Barostim implant completed at The Mount Sinai Hospital
CVRx announced the completion of its 6th Barostim implant at The Mount Sinai Hospital, highlighting a growing adoption of its innovative therapy for patients. The achievement was credited to the ...
Barostim implant rollout at Staten Island University Hospital advances device availability, CVRx initiative
CVRx has announced a partnership with Staten Island University Hospital to deliver the hospital's first Barostim implant. This collaboration involved Dr. Kenneth Dulnuan, Dr. Jonathan Schor, ...
CVRx unveils Barostim therapy to target underlying causes of heart failure
CVRx is introducing Barostim, a therapy aimed at targeting the underlying physiology of heart failure to improve how patients feel and function. Philip Adamson, MD, MSc, FACC, FESC, FRCP (Ed), ...
Podcast appearance by CVRx executive spotlights heart failure treatment evolution
CVRx's Chief Medical Officer, Philip Adamson, MD, MSc, FACC, FESC, FRCP (Ed), recently participated in the Moving the Needle in Medicine podcast hosted by Dr. Adam Hajduczok. During the ...
CVRx partners with Froedtert Menomonee Falls Hospital on first Barostim implant to expand heart failure therapy
CVRx has partnered with Dr. Marc Atzenhoefer, Dr. Abby Rothstein, and the Froedtert Menomonee Falls Hospital team to deliver their first Barostim implant. This collaboration enables patients at ...
CVRx supports #NurMitMedTech push for MedTech sector in Germany
CVRx has joined the #NurMitMedTech campaign initiated by BVMed, aiming to spotlight the importance of the MedTech sector for the German healthcare system and the nation as a business location. ...
CVRx partners with Piedmont Columbus Regional Medical Center for first Barostim implant
CVRx announced a partnership with Piedmont Columbus Regional Medical Center for the center’s first Barostim implant procedure. The collaboration involved Dr. Zulfiquar Bhatti, Dr. Vikramjit ...
Cleveland Clinic Florida adopts Barostim implant in collaboration with CVRx
CVRx has announced a collaboration with Dr. David Baran, Dr. Nicolas Brozzi, Eniley Santi Palacios, APRN, and the medical team at Cleveland Clinic Florida in Weston for their first Barostim ...
CVRx enables first commercial Barostim implant in Washington state for heart failure treatment
CVRx announced its backing of Dr. Josh Grant, Dr. George Shanno, and the Peacehealth Southwest Medical Center team in completing the first commercial Barostim implant in Washington state. The ...
Barostim device rollout gives Prairie Cardiovascular patients novel heart failure therapy option
CVRx announced its support for Prairie Cardiovascular and HSHS St. Elizabeth Hospital as the institutions completed their first Barostim implant procedure. The new device therapy offers patients ...
